UK Pharmacy Benefit Management Services Market

UK Pharmacy Benefit Management Services Market Research Report By Service Type (Claims Management, Formulary Management, Drug Utilization Review, Medication Therapy Management), By End User (Pharmacies, Health Plans, Employers, Public Sector), By Service Provider (Standalone Pharmacy Benefit Managers, Health Insurance Companies, Integrated Health Systems) and By Operating Model (Fully-Managed Services, Pass-Through Services, Hybrid Services) - Growth & Industry Forecast 2025 To 2035
ID: MRFR/Pharma/48949-HCR 200 Pages Vikita Thakur, Rahul Gotadki Last Updated: September 17, 2026
UK Pharmacy Benefit Management Services Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.12%
2024 Market Size$ 23.93 Billion
2025 Market Size$ 25.39 Billion
2035 Market Size$ 45.97 Billion
Key Players
CVS Health
Express Scripts
OptumRx
Humana
Cigna
Prime Therapeutics
Trends
  • Increased Focus on Cost Management
  • Adoption of Advanced Technology Solutions
  • Demand for Enhanced Transparency
Opportunities
  • Rising Healthcare Expenditure
  • Shift Towards Value-Based Care
  • Regulatory Changes and Compliance
Request Free Sample

UK Pharmacy Benefit Management Services Market Summary

As per Market Research Future analysis, the UK pharmacy benefit management services market size was estimated at 23.93 USD Billion in 2024. The UK pharmacy benefit-management-services market is projected to grow from 25.39 USD Billion in 2025 to 45.97 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 6.1% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The UK pharmacy benefit-management-services market is experiencing a transformative shift towards cost efficiency and technological integration.

  • The market is witnessing an increased focus on cost management strategies to optimize healthcare spending.
  • Adoption of advanced technology solutions is becoming prevalent, enhancing operational efficiency and patient care.
  • There is a growing demand for enhanced transparency in drug pricing and benefit structures among stakeholders.
  • Key market drivers include rising healthcare expenditure and a shift towards value-based care, influencing service delivery models.

Market Size & Forecast

2024 Market Size 23.93 (USD Billion)
2035 Market Size 45.97 (USD Billion)
CAGR (2025 - 2035) 6.12%

Major Players

CVS Health (US), Express Scripts (US), OptumRx (US), Humana (US), Cigna (US), Prime Therapeutics (US), MedImpact (US), EnvisionRx (US)

UK Pharmacy Benefit Management Services Market Drivers

Rising Healthcare Expenditure

The pharmacy benefit-management-services market is experiencing growth due to the increasing healthcare expenditure in the UK. As the National Health Service (NHS) allocates more funds to pharmaceuticals, the demand for effective management of these benefits rises. In 2023, healthcare spending in the UK reached approximately £200 billion, with a significant portion directed towards prescription medications. This trend indicates a growing need for pharmacy benefit managers to optimize drug utilization and control costs, thereby enhancing the overall efficiency of healthcare delivery. The rising expenditure is likely to drive the adoption of innovative pharmacy benefit-management-services, as stakeholders seek to balance quality care with financial sustainability.

Shift Towards Value-Based Care

The pharmacy benefit-management-services market is witnessing a shift towards value-based care models in the UK. This approach emphasizes patient outcomes and cost-effectiveness, prompting healthcare providers to reassess their pharmacy benefit strategies. As the NHS moves towards a more integrated care system, pharmacy benefit managers are expected to play a crucial role in aligning medication management with patient health outcomes. The focus on value over volume may lead to increased collaboration between pharmacy benefit managers and healthcare providers, fostering innovative solutions that enhance patient care while controlling costs. This trend suggests a transformative phase for the pharmacy benefit-management-services market, as stakeholders prioritize quality and efficiency.

Regulatory Changes and Compliance

The pharmacy benefit-management-services market is influenced by ongoing regulatory changes in the UK healthcare landscape. Recent reforms aimed at improving patient access to medications and ensuring fair pricing have prompted pharmacy benefit managers to adapt their strategies. Compliance with regulations such as the NHS Drug Tariff and the Health and Social Care Act necessitates robust management services to navigate the complexities of drug reimbursement and pricing. As regulations evolve, pharmacy benefit managers are increasingly tasked with ensuring adherence while also striving to maintain cost-effectiveness. This dynamic environment creates opportunities for growth within the pharmacy benefit-management-services market as organizations seek to align with regulatory requirements.

Growing Demand for Specialty Drugs

The pharmacy benefit-management-services market is significantly impacted by the growing demand for specialty drugs in the UK. These high-cost medications, often used to treat complex conditions, require specialized management to ensure appropriate use and cost control. In 2023, specialty drugs accounted for nearly 50% of total drug spending in the UK, highlighting the need for effective pharmacy benefit-management services. As the prevalence of chronic diseases rises, pharmacy benefit managers are increasingly tasked with developing strategies to manage these high-cost therapies. This trend indicates a potential expansion of services within the pharmacy benefit-management-services market, as organizations seek to address the unique challenges posed by specialty medications.

Technological Advancements in Data Analytics

The pharmacy benefit-management-services market is being transformed by technological advancements in data analytics. The ability to analyze large datasets allows pharmacy benefit managers to gain insights into medication utilization patterns, patient outcomes, and cost drivers. In the UK, the integration of advanced analytics tools is becoming essential for optimizing pharmacy benefit strategies. These technologies enable more precise forecasting and decision-making, ultimately leading to improved patient care and reduced costs. As the market evolves, the adoption of data-driven approaches is likely to enhance the effectiveness of pharmacy benefit-management services, positioning organizations to better meet the needs of patients and healthcare providers.

Market Segment Insights

By Type: Claims Management (Largest) vs. Drug Utilization Review (Fastest-Growing)

In the UK pharmacy benefit-management-services market, Claims Management emerges as the largest segment, accounting for a significant portion of the overall market share. This segment's robust performance is driven by the increasing complexity of pharmacy claims and the emphasis on reducing fraud and administrative delays. On the other hand, Drug Utilization Review is quickly becoming the fastest-growing segment due to the heightened focus on ensuring appropriate medication use and minimizing waste through clinical guidelines and patient monitoring. The landscape for these segments is shaped by various trends and drivers. Claims Management is bolstered by advancements in technology that enhance efficiency and accuracy in processing claims. Meanwhile, Drug Utilization Review benefits from the rising awareness among healthcare stakeholders regarding medication safety and adherence to therapeutic guidelines. The overarching goal for both segments is to improve patient outcomes while managing healthcare costs effectively, ensuring a competitive edge in the evolving market.

Claims Management (Dominant) vs. Drug Utilization Review (Emerging)

Claims Management serves as the dominant force within the UK pharmacy benefit-management-services market, characterized by its integral role in streamlining the claims process and optimizing reimbursement. This segment employs advanced analytics and robust technologies to detect anomalies and ensure compliance, which significantly enhances operational efficiency. Conversely, Drug Utilization Review is an emerging segment that focuses on assessing medication use patterns to provide insights for better therapeutic outcomes. Its rapid growth can be attributed to increasing regulations surrounding medication safety and the necessity for personalized medicine approaches. The synergy between these two segments highlights the evolving demands in pharmacy benefit management, ensuring that patient safety and cost management remain prioritized.

By End User: Pharmacies (Largest) vs. Health Plans (Fastest-Growing)

The market share in the UK pharmacy benefit-management-services market is distributed across various end users, including pharmacies, health plans, employers, and the public sector. Pharmacies hold the largest share, capitalizing on their integral role in medication dispensing and patient care. Health plans, while smaller in share, are emerging rapidly due to increasing demand for managed care services and cost control initiatives. Growth trends within this segment are driven by a heightened focus on patient outcomes and cost-effectiveness. Employers are increasingly recognizing the value of pharmacy benefit management in reducing healthcare expenses, leading to a shift in how benefits are structured. Additionally, the public sector's engagement with pharmacy benefit services is evolving, focusing on enhancing accessibility and medication management for varied populations.

Pharmacies (Dominant) vs. Health Plans (Emerging)

Pharmacies are the dominant players in the UK pharmacy benefit-management-services market, leveraging their critical role in delivering medications and health consultations. They form the backbone of patient support, providing pharmaceutical care while managing inventory and pricing strategies. Their widespread presence allows for enhanced patient engagement and adherence to medication regimens. On the other hand, health plans are emerging with innovative solutions aimed at optimizing drug utilization and minimizing costs. They focus on creating value-based care frameworks that align providers and patients toward better health outcomes, thereby addressing financial sustainability in healthcare. This dynamic places health plans in a position to grow rapidly as they adapt to the changing landscape of managed care.

By Service Provider: Standalone Pharmacy Benefit Managers (Largest) vs. Integrated Health Systems (Fastest-Growing)

In the UK pharmacy benefit-management-services market, Standalone Pharmacy Benefit Managers command a significant share of the market, reflecting their established role and influence within the healthcare system. Their operational models are designed specifically for managing pharmacy benefits, allowing them to negotiate effectively with pharmacies and manufacturers, ultimately benefiting health plans and individuals. Health Insurance Companies also hold a pivotal position, albeit slightly smaller compared to Standalone Managers, as they integrate pharmacy benefits into broader health insurance offerings. The growth trends within this market segment indicate a strong trajectory, notably for Integrated Health Systems, which are increasingly seen as the future of care delivery. The demand for comprehensive services that include pharmacy management has prompted these systems to adopt pharmacy benefit services as part of their offering. Factors such as rising healthcare costs and a focus on patient-centered care are driving transformation, with approaches that enhance efficiency while improving health outcomes.

Standalone Pharmacy Benefit Managers (Dominant) vs. Integrated Health Systems (Emerging)

Standalone Pharmacy Benefit Managers are well-established entities in the UK pharmacy benefit-management-services market, characterized by their focus on managing prescription drug benefits independently from other health services. This dominance is rooted in their specialized expertise, allowing them to maximize cost savings and optimize drug therapies for clients. Conversely, Integrated Health Systems are emerging as formidable competitors, blending pharmacy benefits with broader healthcare services. Their holistic approach not only addresses pharmacy needs but also integrates care coordination and chronic disease management, spurred by the increasing trend toward value-based care. The synergy offered by Integrated Systems positions them as a growing force, appealing to payers and providers seeking comprehensive care solutions.

By Operating Model: Hybrid Services (Largest) vs. Fully-Managed Services (Fastest-Growing)

In the UK pharmacy benefit-management-services market, the market share distribution among operating models reveals that hybrid services occupy the largest segment. This comprehensive model combines various service elements, accommodating client needs most effectively. Fully-managed services are gaining traction, reflecting an increasing preference for outsourced solutions that promise efficiency and control, while pass-through services remain a smaller segment due to their less flexible nature.

Hybrid Services: Dominant vs. Fully-Managed Services: Emerging

Hybrid services stand out as the dominant operating model within the UK pharmacy benefit-management-services market, providing clients with tailored solutions that blend the benefits of fully-managed and pass-through services. This adaptability allows for the optimization of costs and resources, meeting varying client needs effectively. On the other hand, fully-managed services are rapidly emerging as a popular choice, especially among organizations seeking to delegate management tasks to specialists, thereby freeing up internal resources. This competitive landscape drives innovation and enhances service offerings, ensuring clients receive comprehensive support for their benefit-management needs.

Get more detailed insights about UK Pharmacy Benefit Management Services Market
Request Free Sample

Key Players and Competitive Insights

The pharmacy benefit-management-services market is currently characterized by a dynamic competitive landscape, driven by the increasing demand for cost-effective healthcare solutions and the integration of advanced technologies. Key players such as CVS Health (US), Express Scripts (US), and OptumRx (US) are strategically positioning themselves through innovation and digital transformation. CVS Health (US) has focused on enhancing its digital capabilities to streamline pharmacy services, while Express Scripts (US) emphasizes personalized medicine and data analytics to improve patient outcomes. OptumRx (US) is leveraging its extensive data resources to optimize drug pricing and enhance patient engagement, collectively shaping a competitive environment that prioritizes efficiency and patient-centric solutions.The market structure appears moderately fragmented, with several players competing for market share through various business tactics. Companies are increasingly localizing their operations and optimizing supply chains to respond to regional demands effectively. This competitive structure allows for a diverse range of services and solutions, fostering innovation and collaboration among key players. The collective influence of these companies is significant, as they drive advancements in technology and service delivery, ultimately benefiting consumers and healthcare providers alike.

In October CVS Health (US) announced a partnership with a leading telehealth provider to integrate virtual care services into its pharmacy benefit management offerings. This strategic move is likely to enhance patient access to healthcare services, particularly in underserved areas, and aligns with the growing trend of telehealth adoption. By combining pharmacy services with telehealth, CVS Health (US) aims to create a more holistic approach to patient care, potentially improving health outcomes and reducing overall healthcare costs.

In September Express Scripts (US) launched a new initiative focused on value-based care, which incentivizes healthcare providers to deliver high-quality care while managing costs. This initiative reflects a broader industry shift towards value-based models, where reimbursement is tied to patient outcomes rather than service volume. By prioritizing quality over quantity, Express Scripts (US) positions itself as a leader in the evolving landscape of pharmacy benefit management, potentially attracting more clients seeking sustainable healthcare solutions.

In August OptumRx (US) expanded its capabilities by acquiring a data analytics firm specializing in artificial intelligence. This acquisition is expected to enhance OptumRx's ability to analyze patient data and predict medication adherence, thereby improving patient outcomes and reducing costs. The integration of AI into pharmacy benefit management services signifies a critical trend towards data-driven decision-making, which could redefine how companies operate in this space.

As of November the competitive trends in the pharmacy benefit-management-services market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among key players are shaping the landscape, fostering innovation and collaboration. The shift from price-based competition to a focus on technology, supply chain reliability, and innovative solutions is evident. Companies that can effectively leverage these trends are likely to differentiate themselves in a crowded market, ultimately enhancing their competitive positioning.

Key Companies in the UK Pharmacy Benefit Management Services Market include

Recent Industry Developments

The UK Pharmacy Benefit Management Services Market has seen notable developments recently, particularly involving companies such as Cigna and CVS Health, which have been focusing on enhancing their service offerings in response to rising healthcare costs and demand for effective medication management. OptumRx has also been expanding its presence in the UK, aiming to streamline the pharmacy benefits process for employers and consumers alike. In terms of current affairs, Aetna’s efforts to integrate digital tools to improve patient adherence to medication are gaining traction, reflecting a broader trend within the sector. 

Additionally, significant mergers and acquisitions have been minimal, with no recent announcements involving Humana, Well Pharmacy, or Day Lewis Pharmacy making headlines in the past few months. Growth in market valuation for companies such as Lloyds Pharmacy indicates a positive outlook amid a strong regulatory framework established by the UK National Health Service. Over the past couple of years, the emphasis on value-based care has increased, influencing pharmacy benefit strategies and shaping the competitive landscape in the UK market. Companies are encouraged to innovate while navigating the evolving healthcare landscape, ensuring better access and adherence to treatments for patients.

Future Outlook

UK Pharmacy Benefit Management Services Market Future Outlook

The Pharmacy Benefit Management Services Market is projected to grow at a 6.12% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare costs.

New opportunities lie in:

  • Integration of AI-driven analytics for personalized medication management.
  • Expansion of telepharmacy services to enhance patient access.
  • Development of value-based pricing models for specialty drugs.

By 2035, the market is expected to achieve robust growth, reflecting evolving healthcare dynamics.

Market Segmentation

UK Pharmacy Benefit Management Services Market Type Outlook

  • Claims Management
  • Formulary Management
  • Drug Utilization Review
  • Medication Therapy Management

UK Pharmacy Benefit Management Services Market End User Outlook

  • Pharmacies
  • Health Plans
  • Employers
  • Public Sector

UK Pharmacy Benefit Management Services Market Operating Model Outlook

  • Fully-Managed Services
  • Pass-Through Services
  • Hybrid Services

UK Pharmacy Benefit Management Services Market Service Provider Outlook

  • Standalone Pharmacy Benefit Managers
  • Health Insurance Companies
  • Integrated Health Systems

Report Scope

MARKET SIZE 2024 23.93(USD Billion)
MARKET SIZE 2025 25.39(USD Billion)
MARKET SIZE 2035 45.97(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.12% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled CVS Health (US), Express Scripts (US), OptumRx (US), Humana (US), Cigna (US), Prime Therapeutics (US), MedImpact (US), EnvisionRx (US)
Segments Covered Type, End User, Service Provider, Operating Model
Key Market Opportunities Integration of advanced analytics and artificial intelligence in pharmacy benefit-management-services market enhances cost efficiency and patient outcomes.
Key Market Dynamics Regulatory changes and technological advancements reshape the competitive landscape of pharmacy benefit management services.
Countries Covered UK

Frequently Asked Questions

What was the overall market valuation of the UK pharmacy benefit-management-services market in 2024?

The overall market valuation was $23.93 Billion in 2024.

What is the projected market valuation for the UK pharmacy benefit-management-services market by 2035?

The projected valuation for 2035 is $45.97 Billion.

What is the expected CAGR for the UK pharmacy benefit-management-services market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 6.12%.

Which companies are considered key players in the UK pharmacy benefit-management-services market?

Key players include CVS Health, Express Scripts, OptumRx, Humana, Cigna, Prime Therapeutics, MedImpact, and EnvisionRx.

What was the valuation of the Claims Management segment in 2024?

The Claims Management segment was valued at $4.79 Billion in 2024.

How much is the Formulary Management segment projected to be worth by 2035?

The Formulary Management segment is projected to reach $10.5 Billion by 2035.

What is the valuation of the Drug Utilization Review segment in 2024?

The Drug Utilization Review segment was valued at $6.17 Billion in 2024.

What is the projected value of the Medication Therapy Management segment by 2035?

The Medication Therapy Management segment is expected to be valued at $14.32 Billion by 2035.

Which end user segment had the highest valuation in 2024?

The Pharmacies end user segment had the highest valuation at $8.0 Billion in 2024.

What is the projected valuation for Health Insurance Companies by 2035?

The projected valuation for Health Insurance Companies by 2035 is $20.0 Billion.

Author
Author Author Profile Vikita Thakur LinkedIn Senior Research Analyst
She holds an experience of about 5+ years in market research and business consulting projects for sectors such as life sciences, medical devices, and healthcare IT. She possesses a robust background in data analysis, market estimation, competitive intelligence, pipeline analysis market trend identification, and consumer behavior insights. Her expertise lies in technical Sales support, client interaction and project management, designing and implementing market research studies, conducting competitive analysis, and synthesizing complex data into actionable recommendations that drive business growth.
Co-Author Co-Author Profile Rahul Gotadki LinkedIn Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.